Skip to main content
Premium Trial:

Request an Annual Quote

NIH to Hire New Associate Director to Handle Biomedical Research Data Activities


This week, the National Institutes of Health said it plans to recruit a new associate director for data science to lead its efforts to capitalize on the growing body of biomedical research data including genomics, imaging, and electronic health records.

This decision is based on a recommendation from a working group of the NIH’s Advisory Committee to the Director that was charged with the responsibility of looking at the current data and informatics challenges associated with biomedical research (BI 12/14/2012).

In a statement announcing the planned hire, NIH Director Francis Collins said that the institute “aims to play a catalytic lead role” in addressing complex issues associated with biomedical data internally as well as “with stakeholders in the research community, other government agencies, and private organizations involved in scientific data generation, management, and analysis."

For now, Eric Green has been tapped to serve as the acting associate director whilst continuing in his current role as director of the National Human Genome Research Institute.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.